| Head & Heart Psychotherapy Services, Pllc | |
|
2385 S Huron Pkwy Ste 2n Ann Arbor MI 48104-5127 | |
| (734) 408-1395 | |
| Not Available |
| Full Name | Head & Heart Psychotherapy Services, Pllc |
|---|---|
| Speciality | Social Worker |
| Location | 2385 S Huron Pkwy Ste 2n, Ann Arbor, Michigan |
| Authorized Official Name and Position | Michelle R Defrancesco (LMSW) |
| Authorized Official Contact | 7344081395 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Head & Heart Psychotherapy Services, Pllc 210 Pleasant Pl Ann Arbor MI 48103-3924 Ph: (734) 408-1395 | Head & Heart Psychotherapy Services, Pllc 2385 S Huron Pkwy Ste 2n Ann Arbor MI 48104-5127 Ph: (734) 408-1395 |
| NPI Number | 1114597671 |
|---|---|
| Provider Enumeration Date | 06/28/2021 |
| Last Update Date | 06/28/2021 |
| Certification Date | 06/28/2021 |
| Medicare PECOS PAC ID | 5890163364 |
|---|---|
| Medicare Enrollment ID | O20221115002368 |
News Archive
Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based COVID-19 vaccine mRNA-1273 (Moderna). The trial findings reveal that the fractional dose regimen of the Moderna vaccine is well tolerated and safe and is capable of inducing robust antibody responses in vaccine recipients. The study is currently available on the medRxiv* preprint server.
Seegene, Inc., a leader in multi-pathogen diagnostic testing, today announced that it has been awarded patent in the U.S. and Europe for Annealing Control Primer (ACP), a new technology for amplifying a specific region of a gene with much higher specificity and reproducibility than conventional approaches.
Recent research results from the TGF-beta and cancer research group at the Bellvitge Biomedical Research Institute, within IT-Liver, a collaborative European action among several research groups led by Dr. Isabel Fabregat, provide a better understanding of the role of the TGF-beta cytokine in liver cancer.
Eliminating bacteria's DNA and boosting antimicrobial proteins that already exist may help prevent middle ear infections from reoccurring. These are the findings from a Nationwide Children's Hospital study that examined how an immune defense protein common in the middle ear interacts with a structure meant to protect a colony of bacteria.
In a research study appearing in the journal Cancer Cell on March 14, scientists from Cold Spring Harbor Laboratory and four other institutions have identified a strategy for targeted molecular therapy in liver cancer, which currently has limited treatment options and one of the worst one-year survival rates of any cancer type.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114597671 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Michelle Defrancesco |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1891261533 PECOS PAC ID: 9739433681 Enrollment ID: I20181113002684 |
News Archive
Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based COVID-19 vaccine mRNA-1273 (Moderna). The trial findings reveal that the fractional dose regimen of the Moderna vaccine is well tolerated and safe and is capable of inducing robust antibody responses in vaccine recipients. The study is currently available on the medRxiv* preprint server.
Seegene, Inc., a leader in multi-pathogen diagnostic testing, today announced that it has been awarded patent in the U.S. and Europe for Annealing Control Primer (ACP), a new technology for amplifying a specific region of a gene with much higher specificity and reproducibility than conventional approaches.
Recent research results from the TGF-beta and cancer research group at the Bellvitge Biomedical Research Institute, within IT-Liver, a collaborative European action among several research groups led by Dr. Isabel Fabregat, provide a better understanding of the role of the TGF-beta cytokine in liver cancer.
Eliminating bacteria's DNA and boosting antimicrobial proteins that already exist may help prevent middle ear infections from reoccurring. These are the findings from a Nationwide Children's Hospital study that examined how an immune defense protein common in the middle ear interacts with a structure meant to protect a colony of bacteria.
In a research study appearing in the journal Cancer Cell on March 14, scientists from Cold Spring Harbor Laboratory and four other institutions have identified a strategy for targeted molecular therapy in liver cancer, which currently has limited treatment options and one of the worst one-year survival rates of any cancer type.
› Verified 5 days ago
News Archive
Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based COVID-19 vaccine mRNA-1273 (Moderna). The trial findings reveal that the fractional dose regimen of the Moderna vaccine is well tolerated and safe and is capable of inducing robust antibody responses in vaccine recipients. The study is currently available on the medRxiv* preprint server.
Seegene, Inc., a leader in multi-pathogen diagnostic testing, today announced that it has been awarded patent in the U.S. and Europe for Annealing Control Primer (ACP), a new technology for amplifying a specific region of a gene with much higher specificity and reproducibility than conventional approaches.
Recent research results from the TGF-beta and cancer research group at the Bellvitge Biomedical Research Institute, within IT-Liver, a collaborative European action among several research groups led by Dr. Isabel Fabregat, provide a better understanding of the role of the TGF-beta cytokine in liver cancer.
Eliminating bacteria's DNA and boosting antimicrobial proteins that already exist may help prevent middle ear infections from reoccurring. These are the findings from a Nationwide Children's Hospital study that examined how an immune defense protein common in the middle ear interacts with a structure meant to protect a colony of bacteria.
In a research study appearing in the journal Cancer Cell on March 14, scientists from Cold Spring Harbor Laboratory and four other institutions have identified a strategy for targeted molecular therapy in liver cancer, which currently has limited treatment options and one of the worst one-year survival rates of any cancer type.
› Verified 5 days ago
Mary K Anderson Phd Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 111 N 1st St, Ste 1, Ann Arbor, MI 48104 Phone: 734-327-5934 | |
Jennifer Ratliff-moss Lmsw, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5340 Plymouth Rd, Suite 208, Ann Arbor, MI 48105 Phone: 734-905-6649 Fax: 734-369-3369 | |
Mcevilly Counseling Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 120 E Liberty St # St360, Ann Arbor, MI 48104 Phone: 248-736-7251 | |
Andrea Dewey Lmsw Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 120 E Liberty St Ste 330, Ann Arbor, MI 48104 Phone: 734-255-2990 | |
Enlightened Serenity Counseling Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2075 W Stadium Blvd # 3459, Ann Arbor, MI 48103 Phone: 734-352-7398 | |
Rachel Sienko Lp Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2311 E Stadium Blvd Ste 212-3, Ann Arbor, MI 48104 Phone: 810-279-0149 | |
Blooming Minds Therapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 218 Village Green Blvd Apt 101, Ann Arbor, MI 48105 Phone: 567-281-7525 |